Prof. Dr. Asude Aksoy
Is this your profile? Claim it and verify your details.
Claim profilePerson ↔ Disease
Which diseases does this doctor work on?
-
Breast Neoplasms 7 publicationsSource: OpenAlex / PubMed MeSHView publications
- Lung Neoplasms 7 publications
- Neoplasms 4 publications
- Carcinoma, Non-Small-Cell Lung 4 publications
- Brain Neoplasms 3 publications
- Colonic Neoplasms 2 publications
- Pancreatic Neoplasms 2 publications
- Stomach Neoplasms 2 publications
- Carcinoma 2 publications
- Nasopharyngeal Neoplasms 2 publications
- Nasopharyngeal Carcinoma 2 publications
- Melanoma 2 publications
- Liver Neoplasms 2 publications
- Sarcoma 2 publications
Trust
Where does this information come from?
The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.
- SpecialtyMedical Oncologysaglik.gov.trFrom source
- InstitutionElazığ Fethi Sekin Şehir Hastanesisaglik.gov.trFrom source
- Area of workBreast NeoplasmsExtracted from 7 publications · Model version —From source
- Publications85 publicationsOpenAlex, ORCIDFrom source
- ORCID0000-0002-5609-9658ORCIDFrom source
- Last synchronised5 November 2026 10:36https://elazigsehir.saglik.gov.tr/TR-709433/doktorlarimiz.html#asude-aksoysaglik.gov.tr
Scientific work
Publications on Breast Neoplasms
-
Clinical Features and Survival Outcomes in Primary Intestinal Lymphoma: A Multicenter Retrospective Study
Eurasian Journal of Medical Investigation, 2026
DOI 10.14744/ejmi.2612646 Source: OpenAlex
-
Evaluation of the efficacy and tolerability of bevacizumab-based treatments in recurrent primary brain tumors: a multicenter real-world Turkish Oncology Group (TOG) study
BMC Cancer, 2026
DOI 10.1186/s12885-026-15725-9 PMID 41691201 Open-access full textSource: OpenAlex
-
A multi-center case-control study on osteoporosis risk in cancer patients receiving chemotherapy.
Journal of Clinical Oncology, 2025
DOI 10.1200/jco.2025.43.16_suppl.12033 Source: OpenAlex
-
Real-World Treatment Efficacy of Ribociclib or Palbociclib Plus Fulvestrant in Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study
Clinical Breast Cancer, 2025
DOI 10.1016/j.clbc.2025.03.003 PMID 40190010 2 citations (Europe PMC) Open-access full textSource: OpenAlex
-
A multicenter prospective matched comparative study on osteoporosis risk in cancer patients receiving chemotherapy
Supportive Care in Cancer, 2025
DOI 10.1007/s00520-025-09973-x PMID 41225034 1 citation (Europe PMC) Source: OpenAlex
-
The effect of music-supported acceptance and commitment therapy on perceived stress and pain in cancer patients
Revista da Associação Médica Brasileira, 2025
DOI 10.1590/1806-9282.20241027 PMID 40332256 Open-access full textSource: ORCID
-
Co-existence of Myasthenia Gravis and Addison's Disease Without Thymoma: A Case Report.
PubMed, 2025
PMID 41420885 Source: OpenAlex
-
Activity of CDK4/6 inhibitors and parameters affecting survival in elderly patients in age-subgroups: Turkish Oncology Group (TOG) retrospective study
BMC Cancer, 2024
DOI 10.1186/s12885-024-13357-5 PMID 39736618 4 citations (Europe PMC) Open-access full textSource: OpenAlex
-
The knockdown of stathmin with si-RNA inhibits invasion of mesothelioma
Tissue and Cell, 2024
DOI 10.1016/j.tice.2024.102303 PMID 38244401 Open-access full textSource: OpenAlex
-
The evaluation of cyclin D1 expression in prostate carcinoma cases
Northern Clinics of Istanbul, 2024
DOI 10.14744/nci.2023.79735 PMID 39650327 Open-access full textSource: OpenAlex